For CHB patients with normal or minimally increased ALT levels, the overall treatment goal is to inhibit and even eliminate hepatitis B virus infection, alleviate necrosis and inflammation, and suppress the disease progression. The gene discussed is GPT; the disease is hepatitis B virus infection.